Noom
Noom started as a behavior-change app focused on psychology-driven weight loss coaching, built around cognitive behavioral therapy (CBT) principles. In 2023, they launched Noom Med, adding GLP-1 prescriptions to their platform. This makes Noom one of the few providers that combines medication with a structured behavioral curriculum — an approach that could help address the weight regain problem associated with GLP-1 discontinuation. The coaching program predates the medication offering by over a
Overview
- Consultation Model
- Hybrid
- Headquarters
- New York, NY
- Shipping
- 3-5 business days
- Lab Testing
- Yes
- Prescriber Info
- Licensed healthcare providers evaluate patients and prescribe based on clinical eligibility.
- Founded
- 2008
Pros
- Unique combination of GLP-1 medication with an established CBT-based behavior-change curriculum
- Video consultations required (more thorough clinical evaluation than async providers)
- Over a decade of behavior-change coaching experience predating the medication program
- Personal coach and group coaching included in the price
- Competitive compounded semaglutide pricing ($149/month) for what's included
Cons
- Cannot opt out of the coaching/app component to lower cost
- Noom Med is relatively new (launched 2023)
- No published clinical trial data specifically for the combined Med + coaching program
- No lab testing included
- Pricing has been volatile
Pricing
| Medication | Dose | Price | Billing |
|---|---|---|---|
| semaglutide | microdose | $199 | monthly |
| tirzepatide | 2.5-15mg/week | $349 | monthly |